• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mRNA 癌症疫苗中的 RNA 修饰。

RNA modification in mRNA cancer vaccines.

机构信息

Institute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, 116044, Liaoning, People's Republic of China.

出版信息

Clin Exp Med. 2023 Oct;23(6):1917-1931. doi: 10.1007/s10238-023-01020-5. Epub 2023 Feb 14.

DOI:10.1007/s10238-023-01020-5
PMID:36788153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9928499/
Abstract

RNA modification is manifested as chemically altered nucleotides, widely exists in diverse natural RNAs, and is closely related to RNA structure and function. Currently, mRNA-based vaccines have received great attention and rapid development as novel and mighty fighters against various diseases including cancer. The achievement of RNA vaccines in clinical application is largely attributed to some methodological innovations including the incorporation of modified nucleotides into the synthetic RNA. The selection of optimal RNA modifications aimed at reducing the instability and immunogenicity of RNA molecules is a very critical task to improve the efficacy and safety of mRNA vaccines. This review summarizes the functions of RNA modifications and their application in mRNA vaccines, highlights recent advances of mRNA vaccines in cancer immunotherapy, and provides perspectives for future development of mRNA vaccines in the context of personalized tumor therapy.

摘要

RNA 修饰表现为化学修饰的核苷酸,广泛存在于各种天然 RNA 中,与 RNA 结构和功能密切相关。目前,基于 mRNA 的疫苗作为对抗包括癌症在内的各种疾病的新型强大武器受到了极大的关注和快速发展。RNA 疫苗在临床应用中的成功在很大程度上归因于一些方法学上的创新,包括将修饰核苷酸引入合成 RNA 中。选择最佳的 RNA 修饰旨在降低 RNA 分子的不稳定性和免疫原性,这是提高 mRNA 疫苗疗效和安全性的一项非常关键的任务。本文综述了 RNA 修饰的功能及其在 mRNA 疫苗中的应用,重点介绍了 mRNA 疫苗在癌症免疫治疗方面的最新进展,并从个性化肿瘤治疗的角度为 mRNA 疫苗的未来发展提供了展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa1e/9928499/090a2f517cfc/10238_2023_1020_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa1e/9928499/ce993fc32dc9/10238_2023_1020_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa1e/9928499/19d8ba80867a/10238_2023_1020_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa1e/9928499/830f069e043e/10238_2023_1020_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa1e/9928499/090a2f517cfc/10238_2023_1020_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa1e/9928499/ce993fc32dc9/10238_2023_1020_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa1e/9928499/19d8ba80867a/10238_2023_1020_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa1e/9928499/830f069e043e/10238_2023_1020_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa1e/9928499/090a2f517cfc/10238_2023_1020_Fig4_HTML.jpg

相似文献

1
RNA modification in mRNA cancer vaccines.mRNA 癌症疫苗中的 RNA 修饰。
Clin Exp Med. 2023 Oct;23(6):1917-1931. doi: 10.1007/s10238-023-01020-5. Epub 2023 Feb 14.
2
mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.mRNA 疫苗:癌症免疫治疗新时代的曙光。
Front Immunol. 2022 Jun 2;13:887125. doi: 10.3389/fimmu.2022.887125. eCollection 2022.
3
Synthetic modified messenger RNA for therapeutic applications.用于治疗应用的合成修饰信使 RNA。
Acta Biomater. 2021 Sep 1;131:1-15. doi: 10.1016/j.actbio.2021.06.020. Epub 2021 Jun 13.
4
Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy.mRNA 疫苗在癌症免疫治疗中的潜力和挑战。
Front Immunol. 2022 May 26;13:923647. doi: 10.3389/fimmu.2022.923647. eCollection 2022.
5
Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines.基于脂质的载体用于治疗性基于 mRNA 的抗癌疫苗。
Curr Pharm Des. 2019;25(13):1443-1454. doi: 10.2174/1381612825666190619150221.
6
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
7
mRNA Cancer Vaccines: Construction and Boosting Strategies.mRNA 癌症疫苗:构建与增强策略。
ACS Nano. 2023 Oct 24;17(20):19550-19580. doi: 10.1021/acsnano.3c05635. Epub 2023 Oct 11.
8
Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.mRNA 疫苗在癌症治疗方面的临床进展和正在进行的试验。
Lancet Oncol. 2022 Oct;23(10):e450-e458. doi: 10.1016/S1470-2045(22)00372-2.
9
Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities.mRNA 癌症疫苗的最新进展:应对挑战,把握机遇。
Front Immunol. 2023 Sep 6;14:1246682. doi: 10.3389/fimmu.2023.1246682. eCollection 2023.
10
Advances and prospects of mRNA vaccines in cancer immunotherapy.mRNA 疫苗在癌症免疫治疗中的进展与展望。
Biochim Biophys Acta Rev Cancer. 2024 Mar;1879(2):189068. doi: 10.1016/j.bbcan.2023.189068. Epub 2024 Jan 1.

引用本文的文献

1
Prospects and Challenges of Lung Cancer Vaccines.肺癌疫苗的前景与挑战
Vaccines (Basel). 2025 Aug 5;13(8):836. doi: 10.3390/vaccines13080836.
2
Engineered lipid nanoparticles with synergistic dendritic cell targeting and enhanced endosomal escape for boosted mRNA cancer vaccines.具有协同树突状细胞靶向作用和增强内体逃逸能力的工程化脂质纳米颗粒,用于增强型mRNA癌症疫苗。
Mater Today Bio. 2025 Jul 19;34:102107. doi: 10.1016/j.mtbio.2025.102107. eCollection 2025 Oct.
3
Investigating RNA dynamics from single molecule transcriptomes.从单分子转录组研究RNA动态变化。

本文引用的文献

1
Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity.腺嘌呤碱基编辑器演变为具有低脱靶活性的小而高效的胞嘧啶碱基编辑器。
Nat Biotechnol. 2023 May;41(5):673-685. doi: 10.1038/s41587-022-01533-6. Epub 2022 Nov 10.
2
Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution.BID-seq 定量测序技术在碱基分辨率水平上揭示了哺乳动物 mRNA 中的大量假尿嘧啶核苷。
Nat Biotechnol. 2023 Mar;41(3):344-354. doi: 10.1038/s41587-022-01505-w. Epub 2022 Oct 27.
3
The clinical progress of mRNA vaccines and immunotherapies.
Trends Genet. 2025 Jun 4. doi: 10.1016/j.tig.2025.05.001.
4
Comprehensive Analysis of RNA Modifications Related Genes in the Diagnosis and Subtype Classification of Dilated Cardiomyopathy.扩张型心肌病诊断与亚型分类中RNA修饰相关基因的综合分析
J Inflamm Res. 2025 May 15;18:6331-6345. doi: 10.2147/JIR.S498496. eCollection 2025.
5
The Bright Future of mRNA as a Therapeutic Molecule.信使核糖核酸作为治疗性分子的光明未来。
Genes (Basel). 2025 Mar 26;16(4):376. doi: 10.3390/genes16040376.
6
Current Trends in Messenger RNA Technology for Cancer Therapeutics.癌症治疗中信使核糖核酸技术的当前趋势
Biomater Res. 2025 Apr 9;29:0178. doi: 10.34133/bmr.0178. eCollection 2025.
7
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy.癌症疫苗及其他:纳米技术在免疫疗法中的变革性作用。
Pharmaceutics. 2025 Feb 7;17(2):216. doi: 10.3390/pharmaceutics17020216.
8
Integration of 101 machine learning algorithm combinations to unveil m6A/m1A/m5C/m7G-associated prognostic signature in colorectal cancer.整合101种机器学习算法组合以揭示结直肠癌中与m6A/m1A/m5C/m7G相关的预后特征。
Sci Rep. 2025 Feb 18;15(1):5930. doi: 10.1038/s41598-025-89944-8.
9
Insight into the Interaction Mechanism of Pseudorabies Virus Infection.伪狂犬病病毒感染相互作用机制的深入研究
Biology (Basel). 2024 Dec 4;13(12):1013. doi: 10.3390/biology13121013.
10
mRNA vaccines in the context of cancer treatment: from concept to application.癌症治疗背景下的mRNA疫苗:从概念到应用
J Transl Med. 2025 Jan 6;23(1):12. doi: 10.1186/s12967-024-06033-6.
mRNA 疫苗和免疫疗法的临床进展。
Nat Biotechnol. 2022 Jun;40(6):840-854. doi: 10.1038/s41587-022-01294-2. Epub 2022 May 9.
4
Pytheas: a software package for the automated analysis of RNA sequences and modifications via tandem mass spectrometry.Pytheas:一个通过串联质谱法自动分析 RNA 序列和修饰的软件包。
Nat Commun. 2022 May 3;13(1):2424. doi: 10.1038/s41467-022-30057-5.
5
mA RNA modifications are measured at single-base resolution across the mammalian transcriptome.m⁶A RNA 修饰以单碱基分辨率在哺乳动物转录组中进行测量。
Nat Biotechnol. 2022 Aug;40(8):1210-1219. doi: 10.1038/s41587-022-01243-z. Epub 2022 Mar 14.
6
Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development.用于mRNA疫苗开发的肺腺癌肿瘤抗原和免疫亚型的鉴定
Front Cell Dev Biol. 2022 Feb 21;10:815596. doi: 10.3389/fcell.2022.815596. eCollection 2022.
7
Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.沉默长链非编码 RNA SLC16A1-AS1 通过 miR-143-3p/SLC7A11 信号通路诱导肾细胞癌发生铁死亡。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221077803. doi: 10.1177/15330338221077803.
8
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
9
Drug delivery systems for RNA therapeutics.RNA 治疗药物的递药系统。
Nat Rev Genet. 2022 May;23(5):265-280. doi: 10.1038/s41576-021-00439-4. Epub 2022 Jan 4.
10
Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines.肺腺癌 mRNA 疫苗开发的潜在免疫生物标志物候选物和免疫亚型。
Front Immunol. 2021 Nov 30;12:755401. doi: 10.3389/fimmu.2021.755401. eCollection 2021.